REX AMERICAN RESOURCES Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data REX AMERICAN RESOURCES Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2022	FY2022	FY2024	FY2024	FY2025
Revenue	454	453	487	418	373	775	855	833	642	650
Cost of revenue	383	408	456	397	353	684	806	735	551	557
Gross profit	71	44.2	30.2	20.4	19.5	90.6	48.6	98.2	91.5	93.7
Selling, general and administrative	21.4	24.1	20.6	19.5	17.6	21.5	22.8	29.4	27.1	32.6
Interest income	0.43	1.56	3.51	4.12		0.04	2.84	10
Pre-tax income	56.9	25.4	14.6	6.47	4.21	75.8	47.5	98.5	92.9
Income tax	17.4	-19.5	-22.9	-1.99	-0.55	19	9.54	22.6	21.4	-6.5
Income from continuing operations	32.3			8.46	1.88	47.6	27.7	60.9	58.2
Net income to minority interests	7.19	5.21	5.87	4.22	2.62
Net income	32.3	39.7	31.6	7.43	3	52.4	27.7	60.9	58.2	83
EPS, basic	2.45	3.00	2.45	0.59	0.24	1.46	0.78	1.74	1.65	2.50
EPS, diluted	2.45	3.00	2.45	0.59	0.24	1.46	0.78	1.73	1.65	2.50
Shares, basic (weighted)	13.2	13.2	12.9	12.7	12.4	36	35.4	35	35.3	33.2
Shares, diluted (weighted)	13.2	13.2	12.9	12.7	12.4	36	35.4	35.2	35.3	33.2

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2022	FY2022	FY2024	FY2024	FY2025
Cash and equivalents	189	191	189	180	145	230	69.6	223	196	189
Short-term investments			15	26.1	36.2	25.9	211	155	163	187
Receivables	11.9	12.9	11.4	13	19.7	25.8	25.2	23.2	21.5	14.7
Inventory	17.1	20.8	18.5	35.6	37.4	42.2	48.7	27	31.7	28.4
Other current assets	6.96	7.41	9.28	9.66	12.8	12.5	1.22	1.3	1.12	16.6
Total current assets	227	239	251	271	259	345	373	452	436	448
Property, plant and equipment	183	198	183	163	151	138	135	156	211	272
Lease right-of-use assets				16.2	12.7	11.2	15.2	13	21	17.6
Other non-current assets	6.91	7.45	6.18	17.4	25.3	25.9	23.2	9.14	16.7	4.96
Total assets	454	479	471	501	479	550	580	665	720	798
Accounts payable	9.17	8.15	7.46	18.9	16.6	32.3	34.1	42.1	28.3	38.4
Accrued liabilities	4.28	5.11	9.55	7.76	8.75	13.6	15.3	19.7	16.4	29.6
Total current liabilities	22.5	21.9	17	31.6	30.7	50.5	54.6	66.3	50.4	75.4
Lease liabilities				10.7	7.44	6.39	9.86	8.38	15.4	11.1
Other non-current liabilities	2.1	3.37	4.93	0.28	0.27	2.79	3.03	0.97	2.7	2.41
Total liabilities	0.1	0.12	26.1	46.9	42.2	62.8	68.6	77.2	76.4	95.7
Paid-in capital	146	147	148	149	149	149	0.58	3.77	6.47	0.07
Retained earnings	508	548	580	587	590	612	641	702	560	610
Treasury stock	-314	-314	-335	-335	-355	-181	-194	-192	-206	0
Shareholders' equity	340	381	393	401	385	431	448	514	560	611
Minority interests	47.8	50.4	52.3	52.6	52.4	56.8	63	73.7	83.3	91.3
Total equity	388	432	445	454	437	488	511	588	644	702
Total liabilities and equity	454	479	471	501	479	550	580	665	720	798
Shares outstanding	13.2	13.2	12.6	12.6	12	35.6	34.9	17.5	34.4	32.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2022	FY2022	FY2024	FY2024	FY2025
Net income	39.5	44.9	37.5	11.6	5.62	61.2	37.9	75.9	71.5	95.1
Depreciation and amortization	19.5	21.5	24.8	20.2	18.1	18	18	17.8	15.9	15.3
Stock-based compensation	1.31	1.64	0.67	0.4	0.26	1.75	1.93	6.21	3.64	4.21
Deferred income tax	3.04	-18.6	-23.4	0.14	-1.11	12.7	0.92	14.6	9.8	-3.47
Change in receivables	-2.54	-1.09	1.54	1.59	-6.74	-6.11	0.66	1.98	1.67	6.83
Change in inventory	0.12	-3.65	2.28	17.1	-2.31	-4.8	-6.52	21.8	-4.69	3.25
Cash from operations	69.1	41	47.9	10.3	8.62	91.7	54.8	128	64.2	118
Capital expenditures	-14.2	-24	-10.8	-3.78	-10.4	-5.13	-15.6	-37.7	-71.3	-68.4
Acquisitions		-12	-12	-12
Purchases of investments			-126	-26	-96.2	-88.9	-399	-449	-372	-296
Cash from investing	-7.67	-35.7	-24.6	-14.4	-20.8	5.29	-199	28.4	-72.9	-87.7
Share buybacks	-4.71		-21.9		-19.6	-6.63	-13	0	-14.7	-33.4
Cash from financing	-8.55	-2.61	-25.8	-3.95	-22.4	-11.1	-17	-4.32	-18.5	-37.7
Net change in cash	52.9	2.64	-2.53	-8.04	-34.6	85.9	-161	152	-27.1	-7.52
Free cash flow	54.9	17	37.2	6.57	-1.79	86.6	39.2	90.3	-7.13	49.4
Income taxes paid	7.09	6.92	0.86	0.57	1.27	7.24	2.8	12.7	7.9	6.09

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $42.84 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	22.4%	Gross profit / revenue.
Net margin	18.3%	Net income / revenue.
FCF margin	10.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	21.7%	Cash from operations / revenue.
Return on equity (ROE)	17.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	14.1%	Net income / average total assets.
SG&A / revenue	7.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	11.3%	Capital expenditures / revenue.
D&A / revenue	3.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-8.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	11.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	24.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	36.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	42.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	44.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	94.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	51.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	47.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	59.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	83.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	29.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	68.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	8.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	9.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	10.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	11.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-5.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	21.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	6.88x	Current assets / current liabilities.
Quick ratio	6.06x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	5.70x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	9.9%	Total liabilities / total assets.
Working capital	$391.5M	Current assets - current liabilities.
Tangible book value	$673.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.77x	Revenue / average total assets.
Fixed asset turnover	2.24x	Revenue / average property, plant and equipment.
Inventory turnover	18.5x	Cost of revenue / average inventory.
Days inventory	20 days	365 x average inventory / cost of revenue.
Receivables turnover	28.0x	Revenue / average receivables.
Days sales outstanding	13 days	365 x average receivables / revenue.
Days payables	25 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	8 days	Days inventory + days sales outstanding - days payables.
FCF conversion	56.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	52.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.64	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$19.90	Revenue / diluted weighted shares.
FCF per share	$2.07	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.32	Cash from operations / diluted weighted shares.
Book value per share	$20.36	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$20.36	Tangible book value / shares outstanding.
Cash per share	$11.47	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	2.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.41B	Share price x shares outstanding.
Enterprise value	$1.03B	Market cap + total debt - cash - short-term investments.
P/E	11.7x	Market cap / net income. Only when net income is positive.
P/S	2.14x	Market cap / revenue.
P/B	2.09x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.09x	Market cap / tangible book value, when positive.
P/FCF	20.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.86x	Market cap / cash from operations, when positive.
EV/Sales	1.57x	Enterprise value / revenue.
EV/FCF	15.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.9%	Free cash flow / market cap.
Earnings yield	8.5%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.1%	(Dividends paid + share buybacks) / market cap.
PEG	0.25x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was REX AMERICAN RESOURCES Corp's revenue in fiscal 2025?

REX AMERICAN RESOURCES Corp reported revenue of $650.5M for fiscal 2025, 1.2% higher than the year before.

Was REX AMERICAN RESOURCES Corp profitable in fiscal 2025?

Yes. Net income was $83.0M, a net margin of 12.8%.

How much free cash flow did REX AMERICAN RESOURCES Corp generate in fiscal 2025?

Cash from operations of $117.8M minus capital expenditures of $68.4M left free cash flow of $49.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to REX AMERICAN RESOURCES Corp